J. Zagarella

Spironolactone. I. Disposition and metabolism

Aziz Karim, J. Zagarella, Jeremy D. Hribar et al. · Clinical Pharmacology & Therapeutics · 1976 · 83 citations

Secondary Metabolite, Pharmacotherapy, Pharmacological Study +16

Oxandrolone disposition and metabolism in man

Aziz Karim, R. E. Ranney, J. Zagarella et al. · Clinical Pharmacology & Therapeutics · 1973 · 59 citations

Unchanged Drug, Pharmacotherapy, Oxidative Stress +20

Spironolactone. III. Canrenone—maximum and minimum steady‐state plasma levels

Aziz Karim, J. Zagarella, Thomas C. Hutsell et al. · Clinical Pharmacology & Therapeutics · 1976 · 32 citations

Post Steady-state Half-life, Medicine, Former Half-life +6

Species differences in the metabolism and disposition of spironolactone.

Aziz Karim, C Kook, Donald J. Zitzewitz et al. · Drug Metabolism and Disposition · 1976 · 26 citations

Spironolactone. II. Bioavailability

Aziz Karim, J. Zagarella, Thomas C. Hutsell et al. · Clinical Pharmacology & Therapeutics · 1976 · 25 citations

Pharmaceutical Science, Tablet Preparations, Medicine +13